Benzinga's Top Upgrades
Analysts at Goldman Sachs upgraded Thoratec (NASDAQ: THOR) from “neutral” to “buy.” The target price for Thoratec is set to $46. Thoratec's shares closed at $38.31 on Friday.
Wedbush upgraded Advanced Micro Devices (NYSE: AMD) from “neutral” to “outperform.” The target price for Advanced Micro Devices has been raised from $4.50 to $5. AMD's shares closed at $3.83 on Friday.
Analysts at Cowen & Company upgraded St. Jude Medical (NYSE: STJ) from “underperform” to “market perform.” The target price for St. Jude Medical has been raised from $38 to $53. St. Jude Medical's shares closed at $55.16 on Friday.
Analysts at Miller Tabak upgraded Dunkin' Brands Group (NASDAQ: DNKN) from “hold” to “buy.” The target price for Dunkin' Brands Group has been raised from $46 to $53. Dunkin' Brands Group's shares closed at $45.68 on Friday.
Latest Ratings for THOR
|Dec 2014||SunTrust Robinson Humphrey||Downgrades||Buy||Neutral|
|Nov 2014||Credit Suisse||Upgrades||Neutral||Outperform|
|Nov 2014||Wells Fargo||Upgrades||Market Perform||Outperform|
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.